Literatura académica sobre el tema "Biosafety"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Biosafety".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Biosafety"
Truchaud, A., P. Schnipelsky, H. L. Pardue, J. Place y K. Ozawa. "Increasing the biosafety of analytical systems in the clinical laboratory". Journal of Automatic Chemistry 16, n.º 2 (1994): 67–70. http://dx.doi.org/10.1155/s1463924694000076.
Texto completoVoss, Andreas, Sigfrido Rangel-Frausto y Jan Kluytmans. "Biosafety". Infection Control & Hospital Epidemiology 20, n.º 9 (septiembre de 1999): 644. http://dx.doi.org/10.1017/s0195941700071253.
Texto completoYu, Yingjie, Jianxun Ding, Yunhao Zhou, Haihua Xiao y Guizhen Wu. "Biosafety chemistry and biosafety materials: A new perspective to solve biosafety problems". Biosafety and Health 4, n.º 1 (febrero de 2022): 15–22. http://dx.doi.org/10.1016/j.bsheal.2022.01.001.
Texto completoGalyukova, M. I. "Biosafety Architectonics". Lex Russica 75, n.º 10 (18 de octubre de 2022): 54–67. http://dx.doi.org/10.17803/1729-5920.2022.191.10.054-067.
Texto completoDesrosiers, R. y E. Hunter. "AIDS biosafety". Science 252, n.º 5010 (31 de mayo de 1991): 1231. http://dx.doi.org/10.1126/science.1953906.
Texto completoByers, Karen. "Biosafety Tips". Applied Biosafety 7, n.º 2 (junio de 2002): 94–95. http://dx.doi.org/10.1177/153567600200700209.
Texto completoByers, Karen B. "Biosafety Tips". Applied Biosafety 7, n.º 3 (septiembre de 2002): 164–66. http://dx.doi.org/10.1177/153567600200700311.
Texto completoByers, Karen B. "Biosafety Tips". Applied Biosafety 7, n.º 4 (diciembre de 2002): 250–53. http://dx.doi.org/10.1177/153567600200700408.
Texto completoByers, Karen B. "Biosafety Tips". Applied Biosafety 8, n.º 1 (marzo de 2003): 27–29. http://dx.doi.org/10.1177/153567600300800108.
Texto completoByers, Karen B. "Biosafety Tips". Applied Biosafety 8, n.º 2 (junio de 2003): 81–84. http://dx.doi.org/10.1177/153567600300800207.
Texto completoTesis sobre el tema "Biosafety"
Margaritis, D. "Biosafety and biosecurity : design, construction and facility management". Thesis, University College London (University of London), 2017. http://discovery.ucl.ac.uk/1551533/.
Texto completoLoosen, Katja. "Das Biosafety-Protokoll von Cartagena zwischen Umweltvölkerrecht und Welthandelsrecht". Berlin Logos-Verl, 2005. http://deposit.ddb.de/cgi-bin/dokserv?id=2748303&prov=M&dok_var=1&dok_ext=htm.
Texto completoLoosen, Katja. "Das Biosafety-Protokoll von Cartagena zwischen Umweltvölkerrecht und Welthandelsrecht /". Berlin : Logos Verlag, 2006. http://www.gbv.de/dms/spk/sbb/recht/toc/505260972.pdf.
Texto completoDu, Plessis Marthinus Johannes. "The international political economy of the Cartagena Protocol on biosafety". Thesis, Stellenbosch : Stellenbosch University, 2001. http://hdl.handle.net/10019.1/52543.
Texto completoENGLISH ABSTRACT: The development of the global biotechnology industry largely coincided with the development of the US biotechnology industry. This resulted in this industry's oligopolistic and centralised nature where only a few multinational chemical and pharmaceutical companies control most biotechnology processes and production of commodities emanating from these processes. The governance of biotechnology has, until recently, been dominated by state actors who have endeavoured to secure national interests, including those of large multinational corporations (MNCs) based within their boundaries. The technological ability of developed states to exploit and use unevenly distributed resources to their advantage means that an uneven relationship exists between these and poor developing countries. This has been highlighted by differences in public opinion about the role and application of biotechnology in society. While some opinions favour the use and application of biotechnology to enhance food supplies and boost production levels and trade, other opinions caution against the possible hazards that genetically manipulated organisms (GMOs) hold for the environment and human existence. The commercialisation of biotechnology has resulted in the exponential growth of genetically manipulated crops in especially the United States and countries like Argentina and Canada. These countries produce large surpluses of staple grains such as corn and soya and try to sell these to countries with food supply problems. The clash in commercial interests stemming from developed countries' insistence on the protection of intellectual property rights (IPR) on genetically manipulated (GM) seeds has caused considerable conflict with poor farmers who will not be able to sustain their livelihoods if they cannot save seeds for future harvests. This is one aspect of the problems surrounding the protection of knowledge products that is exacerbated by the scientific uncertainty pertaining to the risk involved with biotechnology. While some observers agitate for precaution with the use of GMOs, others feel that a lack of scientific proof of harm is sufficient grounds for proceeding with developments in biotechnology. Conversely, there are some that feel that biotechnology is market driven instead of human needs driven, ultimately resulting in developing countries receiving very little benefit from it. The Cartagena Protocol on biosafety was drafted to address some of the difficulties involved with the transboundary movement of GMOs. Although it holds very specific advantages for developing countries, as a regulatory framework it is limited in its scope and application. Developing countries are limited in their policy options to address their need to protect biodiversity and secure their food supply. This means that considerable challenges and constraints await these countries in utilising global governance of public goods and building their human and technological capacities.
AFRIKAANSE OPSOMMING: Die ontwikkeling van die globale biotegnologie-industrie het grootliks saamgeval met die ontwikkeling van die Verenigde State se biotegnologie-industrie. Dit het aanleiding gegee tot hierdie industrie se oligopolistiese en gesentraliseerde aard waar slegs enkele multinasionale chemiese en farmaseutiese maatskappye die meeste biotegnologie prosesse en die vervaardiging van kommoditeite uit daardie prosesse beheer. Die regering van biotegnologie was tot onlangs oorheers deur staatsakteurs wie gepoog het om nasionale belange te beskerm, insluitend die belange van multinasionale korporasies (MNK) wat vanuit hulle grondgebied funksioneer. Die tegnologiese vermoë van ontwikkelde state om oneweredig verspreide hulpbronne tot eie gewin te benut beteken dat 'n ongelyke verhouding bestaan tussen hierdie en arm ontwikkelende state. Dit word beklemtoon deur verskille in openbare mening oor die rol en aanwending van biotegnologie in die samelewing. Terwyl sekere opinies ten gunste van die aanwending van biotegnologie vir die verbetering van voedselbronne en produksievlakke en handel is, dui ander opinies op die moontlike gevare wat geneties gemanipuleerde organismes (GMOs) vir die omgewing en menslike voortbestaan inhou. Die kommersialisering van biotegnologie het gelei tot die eksponensiële groei van geneties gemanipuleerde gewasse in veral die Verenigde State en state soos Argentinië en Kanada. Hierdie state produseer groot hoeveelhede stapelgrane soos mielies en soja en poog om dit te verkoop aan state met voedselvoorsieningsprobleme. Die botsing in kommersiële belange wat spruit uit ontwikkelde state se aandrang op die beskerming van intellektuele eiendomsreg op geneties gemanipuleerde saad veroorsaak beduidende konflik met arm landbouers wie nie hulle lewensonderhoud kan verseker as hulle nie saad kan berg vir toekomstige saaiseisoene nie. Dit is een aspek van die problematiek rondom die beskerming van kennisprodukte wat vererger word deur die wetenskaplike onsekerheid wat gepaard gaan met die risiko's van biotegnologie. Terwyl sekere waarnemers vir waaksaamheid pleit in die gebruik van GMOs, is daar ander wat voel dat 'n gebrek aan wetenskaplike bewyse van skade genoegsame gronde is vir die voortsetting van ontwikkelings in biotegnologie. Insgelyks is daar diegene wat meen dat biotegnologie markgedrewe in plaas van menslike behoefte gedrewe is, wat uiteindelik daartoe lei dat ontwikkelende state baie min voordeel daaruit trek. Die Kartagena Protokoloor bioveiligheid is opgestel om van die probleme betrokke by die oorgrens verskuiwing van GMOs aan te spreek. Hoewel dit spesifieke voordele vir ontikkelende state inhou is dit as reguleringsraamwerk beperk in omvang en aanwending. Ontwikkelende state het beperkte beleidsopsies om hulle behoefte om biodiversiteit te beskerm en voedselvoorsiening te verseker, aan te spreek. Dit beteken dat beduidende uitdagings en beperkings hierdie state in die benutting van globale regering van openbare goedere vir die bou van menslike en tegnologiese kapasiteite in die gesig staar.
Agutter, Paula Anne. "Computational fluid dynamics as a tool for quantitative biosafety studies". Thesis, University College London (University of London), 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.286672.
Texto completoモニカ, ラコヴィタ y Monica Racovita. "Policies of genetically modified crops in India: food security and biosafety politics". Thesis, https://doors.doshisha.ac.jp/opac/opac_link/bibid/BB12252585/?lang=0, 2011. https://doors.doshisha.ac.jp/opac/opac_link/bibid/BB12252585/?lang=0.
Texto completoJoy, Faida. "Biosafety Regulation: a comparative analysis of the South African and Ugandan experience". Master's thesis, University of Cape Town, 2014. http://hdl.handle.net/11427/4478.
Texto completoKingiri, Ann Njoki. "An enquiry into biosafety regulations implementation in Kenya : perspectives and roles of scientists". Thesis, Open University, 2009. http://oro.open.ac.uk/54654/.
Texto completoCuevas, Edmund B. "Biosecurity and biosafety systems in the Philippines and New Zealand : A cross-case analysis". Thesis, University of Canterbury. Forestry, 2005. http://hdl.handle.net/10092/6883.
Texto completoWint, Sandra Marie Elizabeth. "Requirements for national capacity building under the framework of the Cartagena Protocol on Biosafety". Thesis, University of Sussex, 2004. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.413315.
Texto completoLibros sobre el tema "Biosafety"
Egziabher, Tewolde Berhan Gebre. Biosafety & biodiversity. Addis Ababa: Environmental Protection Authority, 2010.
Buscar texto completoHeinsohn, Patricia A., Robert R. Jacobs y Beth A. Concoby, eds. Biosafety Reference Manual. 2700 Prosperity Ave., Suite 250 Fairfax, VA 22031: American Industrial Hygiene Association, 1995. http://dx.doi.org/10.3320/978-0-932627-65-0.
Texto completoBrandenberg, Oliver. Biosafety resource book. Rome: Food and Agriculture Organization of the United Nations, 2011.
Buscar texto completoY, Richmond Jonathan y American Biological Safety Association, eds. Anthology of biosafety. Mundelein, IL: American Biological Safety Association, 1999.
Buscar texto completo1940-, Kennedy M. E. y Laboratory Centre for Disease Control (Canada), eds. Laboratory biosafety guidelines. 2a ed. Ottawa: Laboratory Centre for Disease Control, Health Canada, 1996.
Buscar texto completoLaboratory Centre for Disease Control (Canada), Canada. Dept. of National Health and Welfare. y Medical Research Council (Canada), eds. Laboratory biosafety guidelines. Ottawa, Ont: Dept. of National Health and Welfare, 1990.
Buscar texto completoBiosafety Act, 2002. Zomba, Malawi: Govt. Printer, 2003.
Buscar texto completoElizabeth, Hodson de Jaramillo, Sensi Alessandra y Food and Agriculture Organization of the United Nations, eds. Biosafety resource book. Rome: Food and Agriculture Organization of the United Nations, 2011.
Buscar texto completoHambleton, P., J. Melling y T. T. Salusbury, eds. Biosafety in Industrial Biotechnology. Dordrecht: Springer Netherlands, 1994. http://dx.doi.org/10.1007/978-94-011-1352-6.
Texto completoSchmidt, Erwin R. y Thomas Hankeln, eds. Transgenic Organisms and Biosafety. Berlin, Heidelberg: Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-642-61460-6.
Texto completoCapítulos de libros sobre el tema "Biosafety"
Falkner, Robert. "Biosafety". En Essential Concepts of Global Environmental Governance, 24. Second edition. | Abingdon, Oxon; New York: Routledge, 2021.: Routledge, 2020. http://dx.doi.org/10.4324/9780367816681-10.
Texto completoGupta, Aarti. "Biotechnology and Biosafety". En The Handbook of Global Climate and Environment Policy, 89–106. Oxford, UK: John Wiley & Sons Ltd, 2013. http://dx.doi.org/10.1002/9781118326213.ch6.
Texto completoGupta, Varsha, Manjistha Sengupta, Jaya Prakash y Baishnab Charan Tripathy. "Biosafety and Bioethics". En Basic and Applied Aspects of Biotechnology, 503–20. Singapore: Springer Singapore, 2016. http://dx.doi.org/10.1007/978-981-10-0875-7_24.
Texto completoKavanagh, Vanessa y Linda Hall. "Biology and Biosafety". En Triticale, 3–13. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-22551-7_1.
Texto completoMertsching, Jürgen. "Biosafety und Biosecurity". En Handbuch für mikrobiologische Laboratorien der Schutz- und Sicherheitsstufen 1–4, 1–31. Wiesbaden: Springer Fachmedien Wiesbaden, 2022. http://dx.doi.org/10.1007/978-3-658-34105-3_1.
Texto completoFleming, Diane O. "Prudent Biosafety Practices". En Biological Safety, 361–71. Washington, DC, USA: ASM Press, 2014. http://dx.doi.org/10.1128/9781555815899.ch19.
Texto completoten Have, Henk y Maria do Céu Patrão Neves. "Safety (See Biosafety)". En Dictionary of Global Bioethics, 939. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-54161-3_463.
Texto completoten Have, Henk y Maria do Céu Patrão Neves. "Biosafety (See Biosecurity)". En Dictionary of Global Bioethics, 199. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-54161-3_96.
Texto completoSinha, Archana y Pramod Kumar Pandey. "Biosafety and Hygiene". En Breeding and Culture of Freshwater Ornamental Fish, 195–208. London: CRC Press, 2023. http://dx.doi.org/10.1201/9781003456858-12.
Texto completoLudlow, Karinne, Stuart J. Smyth y José Falck-Zepeda. "Ensuring Functional Biosafety Systems". En Socio-Economic Considerations in Biotechnology Regulation, 277–93. New York, NY: Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-9440-9_19.
Texto completoActas de conferencias sobre el tema "Biosafety"
BAKANIDZE, LELA, PAATA IMNADZE, SHOTA TSANAVA y NIKOLOZ TSERTSVADZE. "NEW GEORGIAN LEGISLATION ON BIOSAFETY". En The 32nd Session of International Seminars and International Collaboration. WORLD SCIENTIFIC, 2005. http://dx.doi.org/10.1142/9789812701787_0025.
Texto completoKassirov, I. S. y A. S. Dolgova. "DEVELOPMENT OF EXPRESSION CASSETTE FOR EFFICIENT PRODUCTION OF NS1 PROTEIN OF THE DENGE VIRUS". En Molecular Diagnostics and Biosafety. Federal Budget Institute of Science 'Central Research Institute for Epidemiology', 2020. http://dx.doi.org/10.36233/978-5-9900432-9-9-209.
Texto completoNagornykh, A. M., A. I. Tyumentsev, M. A. Tyumentseva y V. G. Akimkin. "ANALYSIS OF PROMISING OPPORTUNITIES FOR THE USE OF GENOME EDITING TECHNOLOGIES IN CATTLE AND PIG INDUSTRY IN TERMS OF SURVIVAL OF YOUNG ANIMALS IN THE NEONATAL PERIOD". En Molecular Diagnostics and Biosafety. Federal Budget Institute of Science 'Central Research Institute for Epidemiology', 2020. http://dx.doi.org/10.36233/978-5-9900432-9-9-104.
Texto completoBelyaeva, V. V., N. V. Kozyrina, U. А. Kuimova, М. D. Goliusova y А. N. Narkevich. "BEHAVIOURAL PATTERNS FOR PROPHYLAXIS OF COVID-19: SURVEY OF MEDICAL PROFESSIONALS AND AIDS PATIENTS". En Molecular Diagnostics and Biosafety. Federal Budget Institute of Science 'Central Research Institute for Epidemiology', 2020. http://dx.doi.org/10.36233/978-5-9900432-9-9-125.
Texto completoTerekhova, M. I., E. V. Rogacheva, I. A. Derevyanchenko y L. A. Kraeva. "WHOLE-GENOME SEQUENCING-BASED ANTIBIOTIC RESISTANCE PROFILE OF LISTERIA MONOCYTOGENES STRAINS FROM SAINT-PETERSBURG AND THE VOLOGDA REGION". En Molecular Diagnostics and Biosafety. Federal Budget Institute of Science 'Central Research Institute for Epidemiology', 2020. http://dx.doi.org/10.36233/978-5-9900432-9-9-109.
Texto completoTyumentsev, A. I., M. A. Tyumentseva y V. G. Akimkin. "DEVELOPMENT OF APPROACHES FOR ENDOTOXIN REMOVAL FROM PROTEIN PREPARATIONS ON THE EXAMPLE OF NUCLEASES OF THE CRISPR/CAS SYSTEM". En Molecular Diagnostics and Biosafety. Federal Budget Institute of Science 'Central Research Institute for Epidemiology', 2020. http://dx.doi.org/10.36233/978-5-9900432-9-9-113.
Texto completoTyumentseva, M. A., A. I. Tyumentsev y V. G. Akimkin. "DEVELOPMENT OF APPROACHES FOR DETECTION OF GENOME-INTEGRATED PROVIRAL DNA OF THE HUMAN IMMUNODEFICIENCY VIRUS (HIV-1) IN ULTRA LOW CONCENTRATIONS USING THE CRISPR/CAS SYSTEM". En Molecular Diagnostics and Biosafety. Federal Budget Institute of Science 'Central Research Institute for Epidemiology', 2020. http://dx.doi.org/10.36233/978-5-9900432-9-9-118.
Texto completoFaizuloev, E. B., A. N. Kaira, T. R. Uzbekov, A. A. Poromov, E. A. Volynskaya, O. A. Svitich y V. V. Zverev. "GENETIC STRUCTURE OF HIGH AND LOW RISK HUMAN PAPILLOMAVIRUSES CIRCULATING IN THE RUSSIAN FEDERATION". En Molecular Diagnostics and Biosafety. Federal Budget Institute of Science 'Central Research Institute for Epidemiology', 2020. http://dx.doi.org/10.36233/978-5-9900432-9-9-123.
Texto completoStashko, T. V. "MAIN CLINICAL AND DEMOGRAPHIC COVID-19 INDICATORS DURING THE MAXIMUM SPREAD SARS-COV-2 PANDEMIC BY THE EXAMPLE OF THE INFECTIOUS HOSPITAL IN THE MOSCOW OBLAST". En Molecular Diagnostics and Biosafety. Federal Budget Institute of Science 'Central Research Institute for Epidemiology', 2020. http://dx.doi.org/10.36233/978-5-9900432-9-9-176.
Texto completoBugorkova, S. A., E. A. Chumachkova, A. L. Kravtsov, S. A. Portenko, V. A. Kozhevnikov, A. Yu Goncharova, E. V. Naidenova, O. V. Kedrova, E. S. Kazakova y S. A. Shcherbakova. "IMMUNOLOGICAL DISORDERS IN PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA DURING THE COVID-19 EPIDEMIC IN SARATOV OBLAST". En Molecular Diagnostics and Biosafety. Federal Budget Institute of Science 'Central Research Institute for Epidemiology', 2020. http://dx.doi.org/10.36233/978-5-9900432-9-9-127.
Texto completoInformes sobre el tema "Biosafety"
King, Bruce W. Biosafety Manual. Office of Scientific and Technical Information (OSTI), mayo de 2010. http://dx.doi.org/10.2172/983284.
Texto completoSiegel, Dina. Principles of Biosafety. Office of Scientific and Technical Information (OSTI), noviembre de 2022. http://dx.doi.org/10.2172/1900435.
Texto completoCaskey, Susan Adele, Jennifer M. Gaudioso, Reynolds Mathewson Salerno, Stefan M. Wagner, Mika Shigematsu, George Risi, Joe Kozlovac, Vibeke Halkjaer-Knudsen y Esmeralda Prat. Biosafety Risk Assessment Methodology. Office of Scientific and Technical Information (OSTI), octubre de 2010. http://dx.doi.org/10.2172/1325209.
Texto completoDickens, Brian Scott, Melanie Ann Chavez, Donovan J. Heimer, Ryan Knudsen y Celina Carmelita Velasquez. Biosafety Level 3 Recon Training. Office of Scientific and Technical Information (OSTI), abril de 2017. http://dx.doi.org/10.2172/1352397.
Texto completoSiegel, Dina. Principles of Biosafety Course # 31701. Office of Scientific and Technical Information (OSTI), septiembre de 2022. http://dx.doi.org/10.2172/1887109.
Texto completoSchuerger, Caroline, Sara Abdulla y Anna Puglisi. Mapping Biosafety Level-3 Laboratories by Publications. Center for Security and Emerging Technology, agosto de 2022. http://dx.doi.org/10.51593/20220019.
Texto completoRevill, James y Kai Ilchmann. Assessing the SecBio Platform Proposal for the Biological Weapons Convention. UNIDIR, diciembre de 2022. http://dx.doi.org/10.37559/wmd/22/bwc/04.
Texto completoSerna, Kassandra y Giulio M. Mancini. Draft Libya Legislative Framework for Biosafety and Biosecurity. Office of Scientific and Technical Information (OSTI), diciembre de 2014. http://dx.doi.org/10.2172/1173190.
Texto completoResearch Institute (IFPRI), International Food Policy. Socioeconomic considerations in biosafety decisionmaking Methods and implementation. Washington, DC: International Food Policy Research Institute, 2013. http://dx.doi.org/10.2499/9780896292079.
Texto completoSiegel, Dina Mary. Biosafety- A Regulatory Primer for DOE/NNSA Sites. Office of Scientific and Technical Information (OSTI), mayo de 2017. http://dx.doi.org/10.2172/1356119.
Texto completo